Recent Updates
Recently added Catalysts
VOR Positive Sentiment

Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Key Takeaway: Vor Bio, a clinical-stage company specializing in cell and genome engineering, will participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference. The company is scheduled for a fireside chat on February 14, 2024, and will also host virtual one-on-one investor meetings. Vor Bio aims to improve treatment standards for blood cancer patients by engineering hematopoietic stem cells to facilitate targeted therapies after transplantation.
Price reaction · baseline $46.4 (2024-02-06 close) · hit after-hours · clean, no other VOR news in the window
day 0 close
-1.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Vor Bio is participating in an important healthcare conference.
  • They are engaging with investors through virtual meetings.
  • The company's efforts focus on innovative therapies for blood cancers.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+442%
120-day peak, hindsight
Typical move
18.8%
average across 6 past catalysts
Cash runway
~55 mo
Minimal dilution risk
Lead asset
Telitacicept
Phase 3 · Primary Sjogren's Disease

Full Press Release Details

CAMBRIDGE, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the Oppenheimer 34th Annual Healthcare Life Sciences Conference.
Oppenheimer 34th Annual Healthcare Life Sciences Conference
Fireside Chat: Wednesday, February 14, 2024 at 10:00 am ET
A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Frequently Asked Questions

When is Vor Bio's fireside chat scheduled?

Vor Bio's fireside chat is on February 14, 2024, at 10:00 am ET.

How can I access the fireside chat?

The chat will be available via live webcast and archived on Vor Bio's website.

What is Vor Bio focusing on?

Vor Bio focuses on changing the treatment standard for blood cancers using engineered stem cells.

Where will the Oppenheimer conference take place?

The Oppenheimer 34th Annual Healthcare Life Sciences Conference is virtual.

What type of meetings will Vor Bio host?

Vor Bio will host virtual one-on-one investor meetings during the conference.

Last updated: Feb 7, 2024